Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the risk of mortality. This study...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:EClinicalMedicine
Päätekijät: Klumb, Christof, Lehmann, Thomas, Aschenbach, René, Eckardt, Niklas, Teichgräber, Ulf
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890981/
https://ncbi.nlm.nih.gov/pubmed/31832619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.09.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia